Cargando…

Role of AMPK in Regulation of Oxaliplatin-Resistant Human Colorectal Cancer

Oxaliplatin is a platinum analog that can interfere with DNA replication and transcription. Continuous exposure to oxaliplatin results in chemoresistance; however, this mechanism is not well known. In this study, oxaliplatin-resistant (OR) colorectal cancer (CRC) cells of HCT116, HT29, SW480 and SW6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sun Young, Chung, Ye Seo, Park, So Yeon, Kim, So Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687437/ https://www.ncbi.nlm.nih.gov/pubmed/36359211 http://dx.doi.org/10.3390/biomedicines10112690

Ejemplares similares

Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
por: Yoo, Hee Young, et al.
Publicado: (2021)

A Muti-center, Randomized Phase II Study of Oxaliplatin and S-1 versus Capecitabine and Oxaliplatin in Patients with Metastatic Colorectal Cancer
por: Kim, Jung Han, et al.
Publicado: (2015)

Luteolin Synergistically Enhances Antitumor Activity of Oxaliplatin in Colorectal Carcinoma via AMPK Inhibition
por: Jang, Chan Ho, et al.
Publicado: (2022)

WBSCR22 confers oxaliplatin resistance in human colorectal cancer
por: Yan, Dongmei, et al.
Publicado: (2017)

Role of oxaliplatin in the treatment of colorectal cancer
por: Comella, Pasquale, et al.
Publicado: (2009)

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial
por: Kim, Seung Tae, et al.
Publicado: (2014)

Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- and SOD2-Induced Autophagy in Human Colorectal Cancer Cells
por: Jeong, Soyeon, et al.
Publicado: (2019)

Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
por: Sun, Wei, et al.
Publicado: (2021)

Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
por: Choi, Ji Hoon, et al.
Publicado: (2014)

FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression
por: Tong, Jiafeng, et al.
Publicado: (2019)

Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer
por: Chocry, Mathieu, et al.
Publicado: (2022)

Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
por: Baek, Kyung Kee, et al.
Publicado: (2010)

A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2018)

TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability
por: Zhou, Sha, et al.
Publicado: (2021)

Phytosphingosine induces systemic acquired resistance through activation of sphingosine kinase
por: Seo, So Yeon, et al.
Publicado: (2021)

Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer
por: Seo, Yoojeong, et al.
Publicado: (2020)

Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1β axis in mice
por: Huh, Jeong-Eun, et al.
Publicado: (2016)

Licochalcone H Targets EGFR and AKT to Suppress the Growth of Oxaliplatin -Sensitive and -Resistant Colorectal Cancer Cells
por: Lee, Seung-On, et al.
Publicado: (2023)

The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer
por: Lin, Xue, et al.
Publicado: (2015)

Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential
por: Luo, Zheng-Dong, et al.
Publicado: (2023)

Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer
por: Park, Dawon, et al.
Publicado: (2018)

Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance
por: Zhang, Ye, et al.
Publicado: (2017)

Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines
por: Noordhuis, Paul, et al.
Publicado: (2019)

The Effect of Compound Sophora on Fluorouracil and Oxaliplatin Resistance in Colorectal Cancer Cells
por: Yin, WeiHua, et al.
Publicado: (2019)

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer
por: Hsieh, Chi-Che, et al.
Publicado: (2022)

Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011)

Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway
por: Yin, Jiahuan, et al.
Publicado: (2019)

E2F1 inhibits cellular senescence and promotes oxaliplatin resistance in colorectal cancer
por: Gao, Haiyang, et al.
Publicado: (2023)

Cyr61 mediates oxaliplatin resistance in colorectal cancer cells by regulating Bcl-xL expression
por: Song, Yanfang, et al.
Publicado: (2021)

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer
por: Zeng, Kaixuan, et al.
Publicado: (2023)

Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
por: Sun, Xianjun, et al.
Publicado: (2020)

The Role of Cyanidin-3-O-glucoside in Modulating Oxaliplatin Resistance by Reversing Mesenchymal Phenotype in Colorectal Cancer
por: Kurter, Hasan, et al.
Publicado: (2023)

SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells
por: Kim, Young Eun, et al.
Publicado: (2021)

Verification of the role of exosomal microRNA in colorectal tumorigenesis using human colorectal cancer cell lines
por: Noh, Gyoung Tae, et al.
Publicado: (2020)

The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells
por: Huang, Wen-Shih, et al.
Publicado: (2016)

Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells
por: Wang, Mengge, et al.
Publicado: (2022)

STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway
por: Yao, Huihui, et al.
Publicado: (2022)

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer
por: Moutinho, Catia, et al.
Publicado: (2013)

PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
por: Sfakianaki, Maria, et al.
Publicado: (2020)

Localized and triggered release of oxaliplatin for the treatment of colorectal liver metastasis
por: Gogineni, Venkateswara R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9k0vdi3o3ja5s3pp1fll7op9hh